146 related articles for article (PubMed ID: 25450403)
21. Delivery of shRNA using gold nanoparticle-DNA oligonucleotide conjugates as a universal carrier.
Ryou SM; Kim S; Jang HH; Kim JH; Yeom JH; Eom MS; Bae J; Han MS; Lee K
Biochem Biophys Res Commun; 2010 Jul; 398(3):542-6. PubMed ID: 20599759
[TBL] [Abstract][Full Text] [Related]
22. Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery.
Shiao YS; Chiu HH; Wu PH; Huang YF
ACS Appl Mater Interfaces; 2014 Dec; 6(24):21832-41. PubMed ID: 24949657
[TBL] [Abstract][Full Text] [Related]
23. An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells.
Ara MN; Matsuda T; Hyodo M; Sakurai Y; Hatakeyama H; Ohga N; Hida K; Harashima H
Biomaterials; 2014 Aug; 35(25):7110-20. PubMed ID: 24875764
[TBL] [Abstract][Full Text] [Related]
24. Aptamer-based colorimetric detection of platelet-derived growth factor using unmodified gold nanoparticles.
Chang CC; Wei SC; Wu TH; Lee CH; Lin CW
Biosens Bioelectron; 2013 Apr; 42():119-23. PubMed ID: 23202340
[TBL] [Abstract][Full Text] [Related]
25. Gold nanoparticles do not induce myotube cytotoxicity but increase the susceptibility to cell death.
Leite PE; Pereira MR; do Nascimento Santos CA; Campos AP; Esteves TM; Granjeiro JM
Toxicol In Vitro; 2015 Aug; 29(5):819-27. PubMed ID: 25790728
[TBL] [Abstract][Full Text] [Related]
26. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
[TBL] [Abstract][Full Text] [Related]
27. Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo.
Hao Z; Fan W; Hao J; Wu X; Zeng GQ; Zhang LJ; Nie SF; Wang XD
Drug Deliv; 2016; 23(3):874-81. PubMed ID: 24892627
[TBL] [Abstract][Full Text] [Related]
28. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE
J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401
[TBL] [Abstract][Full Text] [Related]
29. AS1411 aptamer-targeted gold nanoclusters effect on the enhancement of radiation therapy efficacy in breast tumor-bearing mice.
Ghahremani F; Kefayat A; Shahbazi-Gahrouei D; Motaghi H; Mehrgardi MA; Haghjooy-Javanmard S
Nanomedicine (Lond); 2018 Oct; 13(20):2563-2578. PubMed ID: 30334677
[TBL] [Abstract][Full Text] [Related]
30. TAT-Bim induces extensive apoptosis in cancer cells.
Kashiwagi H; McDunn JE; Goedegebuure PS; Gaffney MC; Chang K; Trinkaus K; Piwnica-Worms D; Hotchkiss RS; Hawkins WG
Ann Surg Oncol; 2007 May; 14(5):1763-71. PubMed ID: 17206479
[TBL] [Abstract][Full Text] [Related]
31. Smart drug delivery of p-Coumaric acid loaded aptamer conjugated starch nanoparticles for effective triple-negative breast cancer therapy.
Mariadoss AVA; Saravanakumar K; Sathiyaseelan A; Karthikkumar V; Wang MH
Int J Biol Macromol; 2022 Jan; 195():22-29. PubMed ID: 34861273
[TBL] [Abstract][Full Text] [Related]
32. In vivo and in vitro toxicity and anti-inflammatory properties of gold nanoparticle bioconjugates to the vascular system.
Uchiyama MK; Deda DK; Rodrigues SF; Drewes CC; Bolonheis SM; Kiyohara PK; Toledo SP; Colli W; Araki K; Farsky SH
Toxicol Sci; 2014 Dec; 142(2):497-507. PubMed ID: 25260831
[TBL] [Abstract][Full Text] [Related]
33.
Belyanina IV; Zamay TN; Zamay GS; Zamay SS; Kolovskaya OS; Ivanchenko TI; Denisenko VV; Kirichenko AK; Glazyrin YE; Garanzha IV; Grigorieva VV; Shabanov AV; Veprintsev DV; Sokolov AE; Sadovskii VM; Gargaun A; Berezovski MV; Kichkailo AS
Theranostics; 2017; 7(13):3326-3337. PubMed ID: 28900513
[TBL] [Abstract][Full Text] [Related]
34. Enrichment and fluorescence enhancement of adenosine using aptamer-gold nanoparticles, PDGF aptamer, and Oligreen.
Chen SJ; Huang CC; Chang HT
Talanta; 2010 Apr; 81(1-2):493-8. PubMed ID: 20188952
[TBL] [Abstract][Full Text] [Related]
35. A Gold Nanoparticle Platform for the Delivery of Functional TGF-β1 siRNA Into Cancer Cells.
Wu J; Liu B; Wu H; Wu Y; Zhang W; Zhao S; Zhang L; Pan X; Gao W; Wang X; Yuan Y; Zhang Y
J Biomed Nanotechnol; 2016 Apr; 12(4):800-10. PubMed ID: 27301206
[TBL] [Abstract][Full Text] [Related]
36. Smart bomb AS1411 aptamer-functionalized/PAMAM dendrimer nanocarriers for targeted drug delivery in the treatment of gastric cancer.
Barzegar Behrooz A; Nabavizadeh F; Adiban J; Shafiee Ardestani M; Vahabpour R; Aghasadeghi MR; Sohanaki H
Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):41-51. PubMed ID: 27626786
[TBL] [Abstract][Full Text] [Related]
37. Epirubicin loaded super paramagnetic iron oxide nanoparticle-aptamer bioconjugate for combined colon cancer therapy and imaging in vivo.
Jalalian SH; Taghdisi SM; Shahidi Hamedani N; Kalat SA; Lavaee P; Zandkarimi M; Ghows N; Jaafari MR; Naghibi S; Danesh NM; Ramezani M; Abnous K
Eur J Pharm Sci; 2013 Oct; 50(2):191-7. PubMed ID: 23835028
[TBL] [Abstract][Full Text] [Related]
38. Improved in vitro efficacy of gold nanoconstructs by increased loading of G-quadruplex aptamer.
Dam DH; Lee RC; Odom TW
Nano Lett; 2014 May; 14(5):2843-8. PubMed ID: 24689438
[TBL] [Abstract][Full Text] [Related]
39. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
Elbialy NS; Fathy MM; Khalil WM
Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
[TBL] [Abstract][Full Text] [Related]
40. Aptamer-functionalized gold nanoparticles for turn-on light switch detection of platelet-derived growth factor.
Huang CC; Chiu SH; Huang YF; Chang HT
Anal Chem; 2007 Jul; 79(13):4798-804. PubMed ID: 17530743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
